Xenon Pharmaceuticals Inc. Overview
XENE market data
Business OverviewA provider-written description of this company or fund, with its source and observation date.
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.
- Source
- massive
- Observed
- Cadence
- Reference data reviewed periodically
- Status
- fresh
Price HistoryDaily closing prices from recorded market data. The latest point represents the most recent completed daily period; prices can move before the next point appears.
XENE price chart · 1M
- O
- 39.15
- H
- 39.15
- L
- 37.57
- C
- 37.69
- Vol
- 114,188.00
Daily history from Jan 4, 2016
- Source
- US equities market feed
- Observed
- Cadence
- Five-minute page cache; daily and stored hourly bars
- Status
- fresh
Key Stats & PerformanceOpen, range, return and notional-volume facts calculated from daily market bars.
- Open
- $39.15
- Previous Close
- $39.19
- Day High
- $39.15
- Day Low
- $37.57
- 52 Week High
- $72.50
- 52 Week Low
- $33.42
- 7 Day Return
- +0.47%
- 30 Day Return
- +3.08%
- 90 Day Return
- -40.60%
- 1 Year Return
- -2.47%
- Daily Notional Volume
- $4.3M Latest daily bar volume multiplied by its closing price.
Valuation & ProfitabilityProvider-backed valuation, profitability, and range metrics for the selected company. Display-only; never feeds scores or decisions.
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$4.36 Diluted earnings per share over the trailing twelve months.
- Beta
- 0.04 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- -867.3% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $33.38 – $72.66 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $3.7B · P/B 6.09 · P/S 495.37.
Company NewsRecent source-attributed headlines linked to this symbol. Repeated headlines and low-signal items are filtered. Open a headline for its source and context.
10 captured